Lumida
/KRYS
⌘K
Krystal Biotech Inc

Krystal Biotech Inc

KRYS
$354.86USD+3.82%+13.07 today

MARKET CAP

10.5B

P/E (TTM)

47.4x

FWD P/E

37.8x

DAY RANGE

$335 – $356

52W RANGE

$131
$383

AI Summary

Stalk
TrimMedium

KRYS is in a Stage 3 distribution phase following a terminal blow-off top, assigning a medium-term Bearish bias. Short-term price remains below declining 9/21 EMAs and is currently pulling back into that resistance zone without a clear rejection signal. Execution is deferred, with trimming opportunities to be considered upon a rejection at the EMA region near the 9/21 EMA zone.

  • Net revenue of $116.4M in Q1 2026 (+32% YoY; +9% sequential growth).
  • Gross margin of 95%, up from 94% YoY, drives high operational returns.
  • Negative earnings yield suggests potential overvaluation risk.
Full analysis →
Insider Trades41 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 25, 2026SellKRYSJohn Charles ThomasEVP, General Counsel2,000$263.26$10.5B-7.23%+171.92%$526.5K+0.00%Stalk
Jun 4, 2026SellKRYSSuma KrishnanPresident, R&D25,000$308.11$10.5B-7.23%+171.92%$7.7M-0.16%Stalk
Jun 4, 2026SellKRYSKrish S KrishnanPresident and CEO25,000$308.12$10.5B-7.23%+171.92%$7.7M-0.16%Stalk
May 26, 2026SellKRYSJohn Charles ThomasEVP, General Counsel642$302.03$10.5B-7.23%+171.92%$193.9K-100.00%Stalk
Mar 4, 2026SellKRYSKrish S KrishnanPresident and CEO25,000$263.17$10.5B-7.23%+171.92%$6.6M-0.17%Stalk
Mar 4, 2026SellKRYSSuma KrishnanPresident, R&D25,000$263.21$10.5B-7.23%+171.92%$6.6M-0.18%Stalk
Feb 27, 2026SellKRYSKathryn RomanoChief Accounting Officer4,252$274.22$10.5B-7.23%+171.92%$1.2M-4.56%Stalk
Feb 27, 2026SellKRYSKrish S KrishnanPresident and CEO30,584$275.64$10.5B-7.23%+171.92%$8.4M-0.41%Stalk
Feb 27, 2026SellKRYSSuma KrishnanPresident, R&D30,584$275.64$10.5B-7.23%+171.92%$8.4M-0.41%Stalk
Feb 9, 2026SellKRYSKathryn RomanoChief Accounting Officer25,750$162.95$10.5B-7.23%+171.92%$4.2M-0.34%10b5-1Stalk
Dec 4, 2025SellKRYSSuma KrishnanPresident, R&D55,000$200.13$10.5B-7.23%+171.92%$11.0M-0.22%Stalk
Dec 4, 2025SellKRYSKrish S KrishnanPresident and CEO55,000$200.14$10.5B-7.23%+171.92%$11.0M-0.22%Stalk
Jul 14, 2025SellKRYSKrish S KrishnanPresident and CEO35,873$150.39$10.5B-7.23%+171.92%$5.4M-0.27%Stalk
Jul 14, 2025SellKRYSSuma KrishnanPresident, R&D35,873$150.39$10.5B-7.23%+171.92%$5.4M-0.27%Stalk
Jul 9, 2025SellKRYSKrish S KrishnanPresident and CEO14,127$150.27$10.5B-7.23%+171.92%$2.1M-0.16%Stalk
Jul 9, 2025SellKRYSSuma KrishnanPresident, R&D14,127$150.27$10.5B-7.23%+171.92%$2.1M-0.16%Stalk
Mar 13, 2025SellKRYSKrish S KrishnanPresident and CEO50,000$177.79$10.5B-7.23%+171.92%$8.9M-0.33%Stalk
Mar 13, 2025SellKRYSSuma KrishnanPresident, R&D50,000$177.79$10.5B-7.23%+171.92%$8.9M-0.33%10b5-1Stalk
Feb 26, 2025SellKRYSKathryn RomanoChief Accounting Officer8,804$178.17$10.5B-7.23%+171.92%$1.6M-9.88%Stalk
Feb 26, 2025SellKRYSKrish S KrishnanPresident and CEO43,877$178.73$10.5B-7.23%+171.92%$7.8M-0.41%Stalk
Feb 26, 2025SellKRYSSuma KrishnanPresident, R&D43,877$178.73$10.5B-7.23%+171.92%$7.8M-0.41%Stalk
Dec 13, 2024SellKRYSKrish S KrishnanPresident and CEO50,000$164.80$10.5B-7.23%+171.92%$8.2M-0.19%10b5-1Stalk
Dec 13, 2024SellKRYSSuma KrishnanPresident, R&D50,000$164.80$10.5B-7.23%+171.92%$8.2M-0.19%10b5-1Stalk
Sep 12, 2024SellKRYSKrish S KrishnanPresident and CEO50,000$197.77$10.5B-7.23%+171.92%$9.9M-0.22%10b5-1Stalk
Sep 12, 2024SellKRYSSuma KrishnanPresident, R&D50,000$197.77$10.5B-7.23%+171.92%$9.9M-0.22%10b5-1Stalk
Jun 11, 2024SellKRYSKrish S KrishnanPresident and CEO50,000$175.76$10.5B-7.23%+171.92%$8.8M-0.20%10b5-1Stalk
Jun 11, 2024SellKRYSSuma KrishnanPresident, R&D50,000$175.76$10.5B-7.23%+171.92%$8.8M-0.20%10b5-1Stalk
Mar 11, 2024SellKRYSKrish S KrishnanPresident and CEO50,000$170.95$10.5B-7.23%+171.92%$8.5M-0.22%10b5-1Stalk
Mar 11, 2024SellKRYSSuma KrishnanPresident, R&D50,000$170.95$10.5B-7.23%+171.92%$8.5M-0.22%10b5-1Stalk
Feb 28, 2024SellKRYSKrish S KrishnanPresident and CEO9,256$163.08$10.5B-7.23%+171.92%$1.5M-0.28%Stalk
Feb 28, 2024SellKRYSSuma KrishnanPresident, R&D9,256$163.08$10.5B-7.23%+171.92%$1.5M-0.28%Stalk
Feb 28, 2024SellKRYSKathryn RomanoChief Accounting Officer12,314$123.80$10.5B-7.23%+171.92%$1.5M-0.84%10b5-1Stalk
Feb 28, 2024SellKRYSKathryn RomanoChief Accounting Officer15,000$114.80$10.5B-7.23%+171.92%$1.7M+0.00%10b5-1Stalk
Feb 26, 2024SellKRYSSuma KrishnanPresident, R&D2,353$157.00$10.5B-7.23%+171.92%$369.4K-0.15%Stalk
Feb 26, 2024SellKRYSKrish S KrishnanPresident and CEO3,791$157.00$10.5B-7.23%+171.92%$595.2K-0.23%Stalk
Feb 26, 2024BuyKRYSKathryn RomanoChief Accounting Officer19,620$95.33$10.5B-7.23%+171.92%$1.9M+0.43%10b5-1Stalk
Jan 22, 2024SellKRYSKathryn RomanoChief Accounting Officer5,000$91.13$10.5B-7.23%+171.92%$455.6K+0.00%10b5-1Stalk
Dec 11, 2023SellKRYSKrish S KrishnanPresident and CEO50,000$105.67$10.5B-7.23%+171.92%$5.3M-0.39%10b5-1Stalk
Dec 11, 2023SellKRYSSuma KrishnanPresident, R&D50,000$105.67$10.5B-7.23%+171.92%$5.3M-0.39%10b5-1Stalk
Sep 11, 2023SellKRYSKrish S KrishnanPresident and CEO50,000$127.23$10.5B-7.23%+171.92%$6.4M-0.30%10b5-1Stalk
Sep 11, 2023SellKRYSSuma KrishnanPresident, R&D50,000$127.23$10.5B-7.23%+171.92%$6.4M-0.30%10b5-1Stalk